ArticleJMIR research protocols2020
Effectiveness of a Quit Vaping Text Message Program in Promoting Abstinence Among Young Adult E-Cigarette Users: Protocol for a Randomized Controlled Trial.
Article in JMIR research protocols, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04251273 (A Randomized Trial of a Text Message Quit Vaping Intervention for Young Adults), which is not on this map. Cited by 22 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized Trial of a Text Message Quit Vaping Intervention for Young Adults
Who cites it
22 citing papers in PubMed, 4 syntheses or guidelines pooled it, 43 citations in OpenAlex.
- Interventions for quitting vaping.The Cochrane database of systematic reviews · 2025Pooled it
- Health Messaging Strategies for Vaping Prevention and Cessation Among Youth and Young Adults: A Systematic Review.Health communication · 2025Pooled it
- Interventions for quitting vaping.The Cochrane database of systematic reviews · 2025Pooled it
- An International Systematic Review of Prevalence, Risk, and Protective Factors Associated with Young People's E-Cigarette Use.International journal of environmental research and public health · 2022Pooled it
- A pilot feasibility study of a behavioral intervention for nicotine vaping cessation among young adults delivered via telehealth.Drug and alcohol dependence · 2022Trial
- Barriers to quittingPreventive medicine reports · 2026Article
- Psychological and behavioral profiles of combustible vs. e-cigarette users: a narrative review of the implications for tailored non-pharmacological cessation interventions.Frontiers in public health · 2026Review
- Keep e-cigarette vaping away from juveniles: immediate interventions.European respiratory review : an official journal of the European Respiratory Society · 2025Article
- Co-designing a Vaping Cessation Program for Australian Young Adults: A Conceptual Model.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025Article
- Enhancing Text Message Support With Media Literacy and Financial Incentives for Vaping Cessation in Young Adults: Protocol for a Pilot Randomized Controlled Trial.JMIR research protocols · 2025Article
- Examining Quitting Experiences on Quit Vaping Subreddits From 2015 to 2021: Content Analysis.Journal of medical Internet research · 2024Article
- Miscommunication about the US federal Tobacco 21 law: a content analysis of Twitter discussions.Tobacco control · 2023Article
- E-cigarette cessation interest and quit attempts among young adults reporting exclusive e-cigarette use or dual use with other tobacco products: How can we reach them?Tobacco prevention & cessation · 2023Article
- Nicotine Dependence from Electronic Cigarettes Use and Depressive Symptoms Among Adolescents.Kansas journal of medicine · 2023Article
- Smartphone Apps for Vaping Cessation: Quality Assessment and Content Analysis.JMIR mHealth and uHealth · 2022Article
- Reappraising Choice in Addiction: Novel Conceptualizations and Treatments for Tobacco Use Disorder.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022Article
- e-Cigarette Cessation: Content Analysis of a Quit Vaping Community on Reddit.Journal of medical Internet research · 2021Article
- A synthesis of the literature to inform vaping cessation interventions for young adults.Addictive behaviors · 2021Article
- Engaging Rural High School Youth in E-cigarette Prevention and Advocacy.Online journal of interprofessional health promotion · 2021Article
- Young Adults' Vaping, Readiness to Quit, and Recent Quit Attempts: The Role of Co-use With Cigarettes and Marijuana.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMillions of young adults currently vape electronic cigarettes (e-cigarettes), yet little research on vaping cessation interventions exists. Text messaging is a promising, scalable intervention strategy for delivering vaping cessation treatment.
objectiveThis study evaluates the effectiveness of a text message quit vaping program (This is Quitting) in promoting abstinence from e-cigarettes among young adults; examines changes in self-efficacy, perceived social norms, and social support for quitting as hypothesized mediators of effectiveness; and examines if treatment effectiveness is moderated by gender, race, ethnicity, or sexual minority status.
methodsOverall, 2600 young adult (aged 18-24 years) e-cigarette users in the United States will be recruited via web advertisements to participate in the study. Participants will be randomized to This is Quitting or an assessment-only control condition. The primary outcome measure is 30-day vaping abstinence at 7 months post enrollment.
resultsStudy recruitment began on December 18, 2019, and is projected to be completed by spring 2020. The final 7-month follow-up is anticipated to be completed by fall/winter 2020. Because this is the first-ever evaluation of a quit vaping program, we were unable to draw on existing literature to determine the appropriate sample size. Therefore, we examined abstinence rates among an initial pilot sample of 269 participants (This is Quitting: n=148 and control: n=121) who completed the 1-month follow-up to determine the final sample size. The 1-month response rate was 79.2% (213/269), with no difference between arms. Using intention-to-treat analyses that counted nonresponders as still vaping, 30-day abstinence rates were 16.2% (24/148) among those randomized to This is Quitting and 8.3% (10/121) among those randomized to control. A treatment difference of 16% vs 8% is detectable with 80% power at 2-sided alpha=.05 with 260/group (520 total). To detect treatment differences of this magnitude in a 20% subsample (eg, Hispanic or sexual minority young adult e-cigarette users), we will enroll 1300/group (2600 total).
conclusionsThe scientific, clinical, and public health communities are desperate for cessation resources to address vaping among young people. This study is the first-ever comparative effectiveness trial of an intervention to help young people quit vaping. It focuses on evaluating the effectiveness of a theory-grounded, empirically informed text message intervention among young adults. The study is fully powered to examine potentially important subgroup differences among young people who are more vulnerable to e-cigarette use. Although potentially more challenging from a research ethics and pragmatic standpoint, evaluating quit vaping intervention approaches in teens is an important area for future research. Data from this trial will establish a benchmark of effectiveness for other vaping cessation programs and begin to create a body of evidence focused on how best to help young people break free from e-cigarettes.
trial registrationClinicalTrials.gov NCT04251273; https://clinicaltrials.gov/ct2/show/NCT04251273. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/18327.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.